# Application of GHOST-CAP strategy combined with multimodal monitoring in the treatment of a patient with polytrauma complicated by severe traumatic brain injury: a case report

**Authors:** Min Liu, Chaxiang Li, Zhaohui Zhang, Haishuang Mei, Guilan Ban

PMC · DOI: 10.3389/fmed.2026.1748816 · Frontiers in Medicine · 2026-02-11

## TL;DR

A 39-year-old man with severe brain injury and multiple injuries was successfully treated using a new eight-dimensional protocol and real-time monitoring.

## Contribution

The paper introduces the clinical application of the GHOST-CAP protocol combined with real-time multimodal monitoring for ultra-severe TBI.

## Key findings

- The patient's condition improved progressively with the GHOST-CAP strategy and multimodal monitoring.
- The treatment approach demonstrated clinical feasibility in managing ultra-severe TBI with polytrauma.

## Abstract

We report a 39-years-old man who sustained polytrauma with ultra-severe traumatic brain injury (TBI) after a fall from height; for the ultra-severe TBI component we innovatively applied the GHOST-CAP eight-dimensional goal-directed protocol and dynamically adjusted therapeutic targets under real-time guidance from multimodal neurologic monitoring. Following comprehensive management the patient’s condition improved progressively, illustrating the clinical feasibility of applying the GHOST-CAP strategy in conjunction with real-time multimodal neurologic monitoring in a patient with polytrauma complicated by ultra-severe TBI.

## Linked entities

- **Diseases:** traumatic brain injury (MONDO:0858950)

## Full-text entities

- **Genes:** IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, ENO2 (enolase 2) [NCBI Gene 2026] {aka HEL-S-279, NSE}
- **Diseases:** agitation (MESH:D011595), infection (MESH:D007239), Hypoglycemia (MESH:D007003), coagulopathy (MESH:D001778), skull base fracture (MESH:D019292), laceration (MESH:D022125), dehydration (MESH:D003681), leukocytosis (MESH:D007964), Bloody otorrhea (MESH:D002558), hospital-acquired pneumonia (MESH:D000077299), hypothermia (MESH:D007035), alveolar collapse (MESH:D001261), epileptic (MESH:D004827), acute brain injury (MESH:D001930), brain herniation (MESH:D001927), impaired consciousness (MESH:D003244), gastrointestinal nutritional intolerance (MESH:D044342), subarachnoid hemorrhage (MESH:D013345), CL (MESH:D002971), immune dysregulation (OMIM:614878), CAP (OMIM:115650), cerebral injury (MESH:D000070625), Coma (MESH:D003128), axonal injury (MESH:D001480), intracranial (MESH:D001932), neurocritical illness (MESH:D002908), infectious (MESH:D003141), increased ICP (MESH:D019586), cerebral contusion (MESH:D000070624), depressed (MESH:D003866), renal injury (MESH:D007674), aspiration (MESH:D011015), TTM (MESH:D000377), hypocapnia (MESH:D016857), tenderness (MESH:D063806), loss of consciousness (MESH:D014474), cerebral ischemia (MESH:D002545), lung (MESH:D008171), Polytrauma (MESH:D009104), TBI (MESH:D000070642), periorbital edema (MESH:D004487), hyponatremia (MESH:D007010), lung injury (MESH:D055370), Pulmonary infection (MESH:D012141), Injury (MESH:D014947), hepatic or renal dysfunction (MESH:D008107), inflammation (MESH:D007249), cerebral (MESH:D002547), craniocerebral trauma (MESH:D006259), pain (MESH:D010146), relative cerebral hypoperfusion (MESH:D000080822), ischemia (MESH:D007511), fever (MESH:D005334), hypernatremia (MESH:D006955), PTE (MESH:D004834), cerebral vasospasm (MESH:D020301), vomiting (MESH:D014839), hypoxia (MESH:D000860), ONSD (MESH:D019574), brain edema (MESH:D001929)
- **Chemicals:** dexmedetomidine (MESH:D020927), sodium valproate (MESH:D014635), Nutrison (-), Na (MESH:D012964), Glucose (MESH:D005947), levetiracetam (MESH:D000077287), nimodipine (MESH:D009553), Carbon Dioxide (MESH:D002245), mannitol (MESH:D008353), hypertonic saline (MESH:D012965), Midazolam (MESH:D008874), Oxygen (MESH:D010100), propofol (MESH:D015742), remifentanil (MESH:D000077208), blood glucose (MESH:D001786), water (MESH:D014867), ceftazidime (MESH:D002442), esketamine (MESH:C000629870)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12932549/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12932549/full.md

## References

39 references — full list in the complete paper: https://tomesphere.com/paper/PMC12932549/full.md

---
Source: https://tomesphere.com/paper/PMC12932549